Published in Int J Cancer on November 15, 1995
Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology (2012) 10.00
Higher serum testosterone is associated with increased risk of advanced hepatitis C-related liver disease in males. Hepatology (2011) 2.42
Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma. Gastroenterology (2008) 2.36
Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis. Endocr Relat Cancer (2014) 0.95
Hepatocellular carcinoma: a review. J Hepatocell Carcinoma (2016) 0.95
Vitamin intake and liver cancer risk: a report from two cohort studies in China. J Natl Cancer Inst (2012) 0.94
Hepatitis B- and hepatitis C-related hepatocellular carcinomas in the United States: similarities and differences. Hepat Mon (2012) 0.87
Vegetable-based dietary pattern and liver cancer risk: results from the Shanghai women's and men's health studies. Cancer Sci (2013) 0.83
Low prevalence of hepatitis C infection in hepatocellular carcinoma (HCC) cases and population controls in Guangxi, a hyperendemic region for HCC in the People's Republic of China. Br J Cancer (1996) 0.82
Genetic polymorphism of NFKB1 and NFKBIA genes and liver cancer risk: a nested case-control study in Shanghai, China. BMJ Open (2014) 0.80
Individualized hepatocellular carcinoma risk: the challenges for designing successful chemoprevention strategies. World J Gastroenterol (2013) 0.79
Aromatase (CYP19) promoter gene polymorphism and risk of nonviral hepatitis-related hepatocellular carcinoma. Cancer (2011) 0.79
Urinary biomarkers of catechins and risk of hepatocellular carcinoma in the Shanghai Cohort Study. Am J Epidemiol (2015) 0.79
Targeting Androgen Receptor (AR)→IL12A Signal Enhances Efficacy of Sorafenib plus NK Cells Immunotherapy to Better Suppress HCC Progression. Mol Cancer Ther (2016) 0.79
A potential explanation of the reported low prevalence of hepatitis B virus infection in patients with systemic lupus erythematosus. Rheumatol Int (2011) 0.78
Finasteride and methadone use and risk of advanced hepatitis C related liver disease. Dig Dis Sci (2012) 0.78
Urinary isothiocyanates level and liver cancer risk: a nested case-control study in Shanghai, China. Nutr Cancer (2014) 0.77
Prediagnostic levels of serum one-carbon metabolites and risk of hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev (2013) 0.77
Androgen profiles among Egyptian adults considering liver status. J Gastroenterol Hepatol (2007) 0.76
A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol (2000) 13.17
Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst (2003) 6.20
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Lack of protective immunity against reinfection with hepatitis C virus. Science (1992) 4.94
Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst (2004) 4.83
A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev (1994) 4.62
Molecular cloning and sequencing of a human hepatitis delta (delta) virus RNA. Nature (1987) 4.52
Calibration of the dietary questionnaire for a multiethnic cohort in Hawaii and Los Angeles. Am J Epidemiol (2000) 4.46
Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use. Lancet (1983) 4.38
Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet (1992) 4.11
Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk. J Natl Cancer Inst (2000) 4.03
Morbidity and mortality in relation to cigarette smoking in Shanghai, China. A prospective male cohort study. JAMA (1996) 3.77
Singapore Chinese Health Study: development, validation, and calibration of the quantitative food frequency questionnaire. Nutr Cancer (2001) 3.77
Genetic and experimental evidence for cross-species infection by swine hepatitis E virus. J Virol (1998) 3.73
Estrogens and endometrial cancer in a retirement community. N Engl J Med (1976) 3.64
'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer. Nature (1983) 3.63
A spontaneous lower motor neuron disease apparently caused by indigenous type-C RNA virus in wild mice. J Natl Cancer Inst (1973) 3.59
Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci U S A (1994) 3.56
Lassa fever. Epidemiological aspects of the 1970 epidemic, Jos, Nigeria. Trans R Soc Trop Med Hyg (1972) 3.44
Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev (2001) 3.43
Risk factors for cancer of the testis in young men. Int J Cancer (1979) 3.42
Increased cell division as a cause of human cancer. Cancer Res (1990) 3.38
Endogenous hormones as a major factor in human cancer. Cancer Res (1982) 3.30
Endogenous hormones and breast cancer risk. Epidemiol Rev (1993) 3.27
Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer (1991) 3.14
Human hepatitis delta antigen is a nuclear phosphoprotein with RNA-binding activity. J Virol (1988) 3.11
Gender- and smoking-related bladder cancer risk. J Natl Cancer Inst (2001) 3.05
A single antigenomic open reading frame of the hepatitis delta virus encodes the epitope(s) of both hepatitis delta antigen polypeptides p24 delta and p27 delta. J Virol (1988) 2.99
Physical exercise and reduced risk of breast cancer in young women. J Natl Cancer Inst (1994) 2.93
Oral contraceptive use and early abortion as risk factors for breast cancer in young women. Br J Cancer (1981) 2.89
Aspirin use and chronic diseases: a cohort study of the elderly. BMJ (1989) 2.89
Evidence of an X-linked or recessive genetic component to prostate cancer risk. Nat Med (1995) 2.83
Reliability of recall of drug usage and other health-related information. Am J Epidemiol (1982) 2.81
Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst (1997) 2.74
Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees. Proc Natl Acad Sci U S A (2000) 2.70
A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer (2005) 2.62
A population-based case-control study of childhood leukemia in Shanghai. Cancer (1988) 2.59
Cancer incidence in the Mexican-American. J Natl Cancer Inst (1975) 2.54
Serum hormones and the alcohol-breast cancer association in postmenopausal women. J Natl Cancer Inst (2001) 2.43
Toward the primary prevention of cancer. Science (1991) 2.41
Stage and delay in breast cancer diagnosis by race, socioeconomic status, age and year. Br J Cancer (1992) 2.40
Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol Biomarkers Prev (2001) 2.40
Descriptive epidemiology of testicular and prostatic cancer in Los Angeles. Br J Cancer (1979) 2.39
Use of permanent hair dyes and bladder-cancer risk. Int J Cancer (2001) 2.36
Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res (1989) 2.35
Estrogen exposure during gestation and risk of testicular cancer. J Natl Cancer Inst (1983) 2.34
A multipurpose serological survey in Kenya. 2. Results of arbovirus serological tests. Bull World Health Organ (1970) 2.34
Comparison of the BACTEC MGIT 960 with Löwenstein-Jensen medium for recovery of mycobacteria from clinical specimens. Int J Tuberc Lung Dis (2000) 2.29
Decreased mortality in users of estrogen replacement therapy. Arch Intern Med (1991) 2.26
A prospective study of pancreatic cancer in the elderly. Int J Cancer (1994) 2.25
Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst (1990) 2.23
Epidemiology of soy exposures and breast cancer risk. Br J Cancer (2008) 2.22
Occupational differences in rates of lung cancer. J Occup Med (1976) 2.19
"Incessant ovulation" and ovarian cancer. Lancet (1979) 2.18
Characterization of hepatitis delta antigen: specific binding to hepatitis delta virus RNA. J Virol (1990) 2.17
A case-control study of menopausal estrogen therapy and breast cancer. JAMA (1980) 2.15
An epidemiologic study of breast cancer. J Natl Cancer Inst (1974) 2.15
Estrogens and breast cancer. Carcinogenesis (1996) 2.15
Menopausal estrogen therapy and hip fractures. Ann Intern Med (1981) 2.13
Prostate cancer risk and serum levels of insulin and leptin: a population-based study. J Natl Cancer Inst (2001) 2.12
Risk factors for uterine fibroids: reduced risk associated with oral contraceptives. Br Med J (Clin Res Ed) (1986) 2.08
Stroke prevention and oestrogen replacement therapy. Lancet (1989) 2.05
The influence of cigarette smoking, alcohol, and green tea consumption on the risk of carcinoma of the cardia and distal stomach in Shanghai, China. Cancer (1996) 2.05
Follow up study of moderate alcohol intake and mortality among middle aged men in Shanghai, China. BMJ (1997) 2.05
The question of estrogen replacement therapy in patients with a prior diagnosis of breast cancer. Oncology (Williston Park) (1990) 2.04
The growing importance of California arboviruses in the etiology of human disease. Prog Med Virol (1971) 2.04